CXCL12 and metastasis: Upregulation of CXCR4 is accepted to be indicative of shorter overall survival and related to an elevated risk of developing lymph node and liver metastasis via the interaction with CXCL12, which can further promote angiogenesis and the formation of new blood and lymphatic vessels [106].